An external, oversized, porous polyester stent reduces vein graft neointima formation, cholesterol concentration, and vascular cell adhesion molecule 1 expression in cholesterol-fed pigs

Journal of Thoracic and Cardiovascular Surgery

Volumn 124, Issue 5, 2002, Pages 950-956

  Angelini, Gianni D ^a   Lloyd, Clinton ^a   Bush, Ray ^a   Johnson, Jason ^a   Newby, Andrew C ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; POLYESTER; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CONTROLLED STUDY; FOAM CELL; GRAFT FAILURE; HYPERCHOLESTEROLEMIA; NONHUMAN; POROSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SAPHENOUS VEIN GRAFT; STENT; SWINE; VEIN GRAFT;

EID: 0036829030     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2002.127004     Document Type: Article

References (31)

1. Campeau L, Enjalbert M, Lesperance J, Vaislic C, Grondin CM, Bourassa MG. Atherosclerosis and late closure of saphenous vein grafts. Sequential angiographic studies 2 weeks, 1 year, 5 to 7 years and 10 to 12 years after surgery. Circulation. 1983;68(Suppl):II-1-7.
2. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention. Circulation. 1998;97: 916-31.
3. Jeremy JY, Mehta D, Angelini GD. Pathophysiology and treatment of vein graft disease following coronary artery bypass graft surgery. J Drug Dev Clin Pract. 1996;8:135-50.
4. Campeau L, Knatterud GL, Domanski M, Hunninghake DB, White CW, Geller NL, et al. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med. 1997;336:153-62.
5. Mann MJ, Gibbons GH, Kernoff RS, Diet FP, Tsao PS, Cooke JP, et al. Genetic engineering of vein grafts resistant to atherosclerosis. Proc Natl Acad Sci U S A. 1995;92:4502-6.
6. Mannion JD, Ormont ML, Magno MG, O'Brien JE, Shi Y, Zalewski A. Sustained reduction of neointima with c-myc antisense oligonucleotides in saphenous vein grafts. Ann Thorac Surg. 1998;66:1948-52.
7. Ehsan A, Mann MJ, Dell'Acqua G, Dzau VJ. Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy. J Thorac Cardiovasc Surg. 2001;121:714-22.
8. Mann MJ, Whittemorre AD, Donaldson MC, Belkin M, Conte MS, Polak JF, et al. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: The PREVENT single centre randomised controlled trial. Lancet. 1999;354:1493-8.
9. Zwolak RM, Adams MC, Clowes AW. Kinetics of vein graft hyperplasia: Association with tangential stress. J Vasc Surg. 1987;5:126-36.
10. Batellier J, Wassef M, Merval R, Duriez M, Tedgui A. Protection from atherosclerosis in vein grafts by a rigid external support. Arterioscler Thromb. 1993;13:379-84.
11. Kohler T, Kirkman TR, Clowes AW. The effect of rigid external support on vein graft adaptation to the arterial circulation. J Vasc Surg. 1989;9:277-85.
12. Violaris A, Newby A, Angelini G. Effect of external stenting on wall thickening in arteriovenous bypass grafts. Ann Thorac Surg. 1993;55:667-71.
13. George SJ, Izzat MB, Gadsdon P, Johnson JL, Yim APC, Wan S, et al. Macroporosity is necessary for the reduction of neoitnimal and medial thickening by external stenting of porcine saphenous vein bypass grafts. Atherosclerosis. 2001;155:329-36.
14. Angelini GD, Izzat MB, Newby AC. External stenting reduces early medial and intimal thickening in a pig model of arteriovenous bypass grafting. J Thorac Cardiovasc Surg. 1996;112:79-84.
15. Izzat MB, Mehta D, Bryan AJ, Reeves B, Newby AC, Angelini GD. The influence of external stent size on early medial and neointimal thickening in a pig model of saphenous vein bypass grafting. Circulation. 1996;94:1741-5.
16. Mehta D, George SJ, Jeremy JY, Izzat MB, Southgate KM, Bryan AJ, et al. External stenting reduces long term medial and neointimal thickening and platelet derived growth factor expression in a pig model of arteriovenous bypass grafting. Nat Med. 1998;4:235-29.
17. Cybulski M, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, et al. A major role for VCAM-1 but not ICAM-1 in early atherosclerosis. J Clin Invest. 2001;107:1255-62.
18. Angelini GD, Bryan AJ, Williams HMJ, Morgan R, Newby AC. Distention promotes platelet and leukocyte adhesion and reduces short-term patency in pig arteriovenous bypass grafts. J Thorac Cardiovasc Surg. 1990;99:433-9.
19. Angelini GD, Bryan AJ, Williams HMJ, Soyombo AA, Williams A, Tovey J, et al. Timecourse of medial and intimal thickening in pig arteriovenous bypass grafts: Relationship to endothelial injury and cholesterol accumulation. J Thorac Cardiovasc Surg. 1992;103:1093-103.
20. Harrison AA, Stocker CJ, Chapman PT, Tsang YT, Huehns TY, Gundel RH, et al. Expression of vascular cell adhesion molecule-1 by vascular endothelial cells in immune, nonimmune inflammatory, reactions in the skin. J Immunol. 1997;159:4546-54.
21. Stocker CJ, Sugars KL, Yarwood H, Delikouras A, Lechler RI, Dorling A, et al. Cloning of porcine intercellular adhesion molecule-1 and characterization of its induction on endothelial cells by cytokines. Transplantation. 2000;70:579-86.
22. Kissane JM, Robins E. The fluorimetric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system. J Biol Chem. 1958;233:184-8.
23. Zwolak RM, Kirlman TR, Clowes AW. Atherosclerosis in rabbit vein grafts. Arteriosclerosis. 1989;9:374-9.
24. Zhou Y, Dietrich H, Yanhua H, Metzler B, Wick G, Xu Q. Mouse model of vein bypass graft arteriosclerosis. Am J Pathol. 1998;153: 1301-10.
25. Shi Y, O'Brien JE, Mannion JD, Morrison RC, Chung W, Fard A, et al. Remodeling of autologous saphenous vein grafts. The role of perivascular myofibroblasts. Circulation. 1997;95:2684-93.
26. Shi Y, Patel S, Davenpeck KL, Niculescu R, Rodriguez E, Magno MG, et al. Oxidative stress and lipid retention in vascular grafts -comparison between venous and arterial conduits. Circulation. 2001;103:2408-13.
27. Kohler TR, Kirkman T, Clowes AW. Effect of heparin on adaptation of vein grafts to arterial circulation. Atherosclerosis. 1989;9:523-8.
28. Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis prone sites on the endothelium of ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 1998;18:842-51.
29. Iiyama K, Hajra L, Iiyama M, Li HM, DiChiara M, Medoff BD, et al. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res. 1999;85:199-207.
30. O'Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D, et al. Vascular adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest. 1993;92:945-51.
31. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, et al. A major role for VCAM-1 but not ICAM-1 in early atherosclerosis. J Clin Invest. 2001;107:1255-62.